Competing interests Nik Krajnc: has participated in meetings sponsored by, received speaker honoraria or travel funding from BMS/Celgene, Janssen-Cilag, Merck, Novartis, Roche and Sanofi-Genzyme and held a grant for a Multiple Sclerosis Clinical Training Fellowship Programme from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Full medical history is reviewed before any prescription to ensure your safety
Another limitation is the lack of comprehensive dose-response studies
If you are weighing the options between Retatrutide and Tirzepatide, the research data is what convinced me to go with the triple agonist
Injectable forms of semaglutide, such as Ozempic and Wegovy , are typically kept in the fridge before the first use
None of these are FDA-approved cognitive drugs, and the right consideration, if any, depends entirely on a clinical evaluation rather than a chart